{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:19:35Z","timestamp":1772673575750,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1124\/jpet.120.000257","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T18:09:03Z","timestamp":1608746943000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia"],"prefix":"10.1016","volume":"376","author":[{"given":"Yitong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahyar","family":"Khazaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazli","family":"Farahanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Khanifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Farzaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick A.","family":"Haslett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangala M.","family":"Soundarapandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000257_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.120.000257_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trsl.2012.03.003","article-title":"Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis--role of intra-renal angiotensin system","volume":"160","author":"Aminzadeh","year":"2012","journal-title":"Transl Res"},{"key":"10.1124\/jpet.120.000257_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOL.0b013e3283630cf0","article-title":"The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism","volume":"24","author":"Arca","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/jpet.120.000257_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"key":"10.1124\/jpet.120.000257_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/geno.1999.6041","article-title":"Identification of a mammalian angiopoietin-related protein expressed specifically in liver","volume":"62","author":"Conklin","year":"1999","journal-title":"Genomics"},{"key":"10.1124\/jpet.120.000257_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12882-015-0034-4","article-title":"A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro","volume":"16","author":"Dai","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1124\/jpet.120.000257_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12882-019-1383-1","article-title":"Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss","volume":"20","author":"Dai","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1124\/jpet.120.000257_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000494694","article-title":"Underlying mechanisms of renal lipotoxicity in obesity","volume":"143","author":"Escasany","year":"2019","journal-title":"Nephron"},{"key":"10.1124\/jpet.120.000257_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI111548","article-title":"Catabolism of very low density lipoproteins in experimental nephrosis","volume":"74","author":"Garber","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.120.000257_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1705994","article-title":"ANGPTL3 inhibition in homozygous familial hypercholesterolemia","volume":"377","author":"Gaudet","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1194\/jlr.M054890","article-title":"ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys","volume":"56","author":"Gusarova","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.120.000257_bib15","first-page":"246","article-title":"Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome","volume":"5","author":"Han","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1124\/jpet.120.000257_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0022-3565(25)23226-8","article-title":"Kinetics of drug action in disease states. XXIX. Effect of experimental nephrotic syndrome on the pharmacodynamics of heptabarbital: implications of severe hypoalbuminemia","volume":"249","author":"Hoffman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000257_bib17","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/1061186X.2019.1566342","article-title":"ANGPTL3: a novel biomarker and promising therapeutic target","volume":"27","author":"Jiang","year":"2019","journal-title":"J Drug Target"},{"key":"10.1124\/jpet.120.000257_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.ajkd.2013.10.042","article-title":"Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study","volume":"63","author":"Jin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000257_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib20","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1046\/j.1523-1755.1999.07105.x","article-title":"New insights into lipid metabolism in the nephrotic syndrome","volume":"71","author":"Kaysen","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/jpet.120.000257_bib21","first-page":"F335","article-title":"Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis","volume":"263","author":"Kaysen","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.120.000257_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrendo.2017.119","article-title":"Angiopoietin-like 3 in lipoprotein metabolism","volume":"13","author":"Kersten","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1124\/jpet.120.000257_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MOL.0000000000000600","article-title":"New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk","volume":"30","author":"Kersten","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/jpet.120.000257_bib24","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure","volume":"298","author":"Kim","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.120.000257_bib25","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/ki.1997.242","article-title":"Acquired VLDL receptor deficiency in experimental nephrosis","volume":"51","author":"Liang","year":"1997","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000257_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0022-2143(97)90038-X","article-title":"Gene expression of lipoprotein lipase in experimental nephrosis","volume":"130","author":"Liang","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1124\/jpet.120.000257_bib27","doi-asserted-by":"crossref","first-page":"135608","DOI":"10.1155\/2013\/135608","article-title":"Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin \u03b1(V)\u03b23\/FAK\/PI3K pathway-mediated Rac1 activation","volume":"2013","author":"Lin","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1124\/jpet.120.000257_bib28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/pr.2015.38","article-title":"A novel role of angiopoietin-like-3 associated with podocyte injury","volume":"77","author":"Liu","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1124\/jpet.120.000257_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ndt\/gft439","article-title":"Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.120.000257_bib30","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1681\/ASN.2014030267","article-title":"Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics","volume":"25","author":"Mac\u00e9","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000257_bib31","doi-asserted-by":"crossref","first-page":"e0142291","DOI":"10.1371\/journal.pone.0142291","article-title":"Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes","volume":"10","author":"Mart\u00ednez-Garc\u00eda","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000257_bib32","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-1298","article-title":"Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization","volume":"97","author":"Minicocci","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.120.000257_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2741\/4585","article-title":"Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease","volume":"23","author":"Moradi","year":"2018","journal-title":"Front Biosci"},{"key":"10.1124\/jpet.120.000257_bib34","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib35","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.120.000257_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.numecd.2010.10.002","article-title":"Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes","volume":"21","author":"Nosadini","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1124\/jpet.120.000257_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordo\u00f1ez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000257_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cbic.201500023","article-title":"Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo","volume":"16","author":"Rajeev","year":"2015","journal-title":"ChemBioChem"},{"key":"10.1124\/jpet.120.000257_bib39","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000257_bib40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","article-title":"Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids [published correction appears in Arterioscler Thromb Vasc Biol (2013) 33:e124]","volume":"33","author":"Robciuc","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.120.000257_bib41","first-page":"70","article-title":"Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans","volume":"119","author":"Romeo","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.120.000257_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0925-4439(96)00022-1","article-title":"Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats","volume":"1316","author":"Sakurai","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.000257_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1523-1755.2002.00104.x","article-title":"Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis","volume":"61","author":"Sato","year":"2002","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1124\/jpet.120.000257_bib44","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1053\/ajkd.2001.20766","article-title":"Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms","volume":"37","author":"Shearer","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000257_bib45","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000257_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000257_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2015.180","article-title":"HDL abnormalities in nephrotic syndrome and chronic kidney disease","volume":"12","author":"Vaziri","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.120.000257_bib48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.ajkd.2014.04.016","article-title":"Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome","volume":"64","author":"Vaziri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000257_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/hy0102.100540","article-title":"Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency","volume":"39","author":"Vaziri","year":"2002","journal-title":"Hypertension"},{"key":"10.1124\/jpet.120.000257_bib50","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1046\/j.1523-1755.2003.00911.x","article-title":"Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000257_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-011-0549-3","article-title":"Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression","volume":"16","author":"Vaziri","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"Suppl 4","key":"10.1124\/jpet.120.000257_bib52","first-page":"S70","article-title":"Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins","volume":"14","author":"Wheeler","year":"2001","journal-title":"J Nephrol"},{"key":"10.1124\/jpet.120.000257_bib53","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.120.317128","article-title":"LDL-cholesterol reduction by ANGPTL3 inhibition in mice is dependent on endothelial lipase","volume":"127","author":"Wu","year":"2020","journal-title":"Circ Res"},{"key":"10.1124\/jpet.120.000257_bib54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2017.08.031","article-title":"Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol","volume":"268","author":"Xu","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:54:13Z","timestamp":1739973253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0022356524257712"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000257","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}